Full Text View
Tabular View
No Study Results Posted
Related Studies
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
This study is currently recruiting participants.
Verified October 2012 by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Study NCT01030861   Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

First Received on December 11, 2009.   Last Updated on October 9, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Autoantibody Positive
High Risk
Impaired Glucose Tolerance
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 1
Glucose Intolerance
More general conditions related to this trial
Autoimmune Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Hyperglycemia
Immune System Diseases
Metabolic Diseases
Interventions listed in this trial
Teplizumab
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Allergy and Infectious Diseases (NIAID)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Center for Research Resources (NCRR)
Juvenile Diabetes Research Foundation
American Diabetes Association


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services